Enanta Pharmaceuticals ENTA Q1 2025 earnings
Reported May 12, 2025 · Before market open
Revenue$14.9MMiss by $1.0M
EPS-$1.06Miss by $0.02
Revenue estimate$16.0M
EPS estimate-$1.04
Next report
Aug 10, 2026 (In 1 week)Revenue estimate$16.8M
EPS estimate-$0.51
Versus estimates
Revenue
Diluted EPS
Ask the moment Enanta Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Enanta Pharmaceuticals report Q1 2025 earnings?
- Enanta Pharmaceuticals (ENTA) reported Q1 2025 earnings on May 12, 2025 before market open.
- What were Enanta Pharmaceuticals's Q1 2025 revenue and EPS?
- Enanta Pharmaceuticals reported revenue of $14.9M and eps of $-1.06 for Q1 2025.
- Did Enanta Pharmaceuticals beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $16.0M by $1.0M. EPS missed the consensus estimate of $-1.04 by $0.02.
- How did Enanta Pharmaceuticals's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 12.5% from $17.1M a year earlier and eps grew 27.9% from $-1.47.
- Where can I find Enanta Pharmaceuticals's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-071340) directly on SEC EDGAR. The filing index links above go to sec.gov.